Home » Pharma Blog Watch
Pharma Blog Watch
FavId Shows Promise
for relapsed NHL patients (The Pharm Voice)
In her blog, Gloria Gamat
discusses Favrille's recently announced results of a Phase II trial of its non-Hodgkin's
lymphoma (NHL) drug FavId.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May